Literature DB >> 26144899

A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection.

Juliana Gil Melgaço1, Lucas Nóbrega Morgado2, Marta Almeida Santiago3, Jaqueline Mendes de Oliveira4, Lia Laura Lewis-Ximenez5, Bárbara Hasselmann6, Oswaldo Gonçalves Cruz7, Marcelo Alves Pinto8, Claudia Lamarca Vitral9.   

Abstract

Based on current studies on the effects of single dose vaccines on antibody production, Latin American countries have adopted a single dose vaccine program. However, no data are available on the activation of cellular response to a single dose of hepatitis A. Our study investigated the functional reactivity of the memory cell phenotype after hepatitis A virus (HAV) stimulation through administration of the first or second dose of HAV vaccine and compared the response to that of a baseline group to an initial natural infection. Proliferation assays showed that the first vaccine dose induced HAV-specific cellular response; this response was similar to that induced by a second dose or an initial natural infection. Thus, from the first dose to the second dose, increase in the frequencies of classical memory B cells, TCD8 cells, and central memory TCD4 and TCD8 cells were observed. Regarding cytokine production, increased IL-6, IL-10, TNF, and IFNγ levels were observed after vaccination. Our findings suggest that a single dose of HAV vaccine promotes HAV-specific memory cell response similar to that induced by a natural infection. The HAV-specific T cell immunity induced by primary vaccination persisted independently of the protective plasma antibody level. In addition, our results suggest that a single dose immunization system could serve as an alternative strategy for the prevention of hepatitis A in developing countries.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cellular response; Central memory cells; Effector memory cells; Hepatitis A vaccine; Single dose

Mesh:

Substances:

Year:  2015        PMID: 26144899     DOI: 10.1016/j.vaccine.2015.06.099

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

2.  Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?

Authors:  Juliana Gil Melgaço; Tamiris Azamor; Ana Paula Dinis Ano Bom
Journal:  Cell Immunol       Date:  2020-04-28       Impact factor: 4.868

Review 3.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

4.  Evidence of Circulation of Several HAV Genetic Variants and Emergence of Potential Antigenic Variants in an Endemo-Epidemic Country before Vaccine Introduction.

Authors:  Kaouther Ayouni; Anissa Chouikha; Oussema Khamessi; Henda Touzi; Walid Hammemi; Henda Triki
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

5.  The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

Authors:  Desmond Curran; Marc de Ridder; Thierry Van Effelterre
Journal:  Hum Vaccin Immunother       Date:  2016-07-18       Impact factor: 3.452

6.  Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil.

Authors:  Wagner Izidoro de Brito; Eduardo Rodrigues Alves-Junior; Rode Martinho de Oliveira; Francisco José Dutra Souto
Journal:  Braz J Infect Dis       Date:  2018-04-21       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.